Exploring the sortilin related receptor, SorLA, in depression
Henriette N Buttenschøn1, Betina Elfving2, Marit Nielsen2
1Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Journal of Affective Disorders
|March 3, 2018
Summary
Serum SorLA levels may aid in depression diagnosis when combined with other factors. While not a standalone biomarker, SorLA levels increased with nortriptyline treatment in depressed individuals.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Individual depression biomarkers lack clinical sensitivity and specificity.
- The sorting-related receptor with A-type repeats (SorLA) is linked to Alzheimer's and neurological disorders.
- The SORCS3 gene is associated with depression, and sortilin levels are reduced in depressed individuals.
Purpose of the Study:
- To investigate the role of serum SorLA levels in depression.
- To determine if SorLA can serve as a biomarker for depression diagnosis or treatment response.
Main Methods:
- Serum SorLA levels were measured using ELISA in two clinical samples.
- Generalized linear models were employed for statistical analysis.
- Multivariate models were developed to discriminate between depressed individuals and healthy controls.
Main Results:
- A multivariate model including serum SorLA, previous depressive episodes, stressful life events, sortilin, and VEGF differentiated depressed individuals from controls.
- No significant difference in SorLA levels was found between depressed individuals and healthy controls as an isolated factor.
- Serum SorLA levels significantly increased after 12 weeks of nortriptyline treatment, but not escitalopram.
Conclusions:
- SorLA, in combination with other factors, may support depression diagnosis.
- SorLA is not a reliable individual biomarker for depression.
- SorLA is not indicative of treatment response to escitalopram but may be influenced by nortriptyline.
Related Concept Videos
Long-term Depression
33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression
3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation
40.7K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.7K
Depressants
474
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
474
Depression: Overview
935
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
935
Depressive Disorders: Etiology
679
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
679


